Mingfang Zhao

机构：Kunming University, Qingdao Agricultural University, First Hospital of China Medical University, Command Hospital, China Medical University

发表论文 31 篇 · 总被引 336 次 · h-index 11

代表论文

• Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study (2024 · Journal of Thoracic Oncology · 被引 52)
• Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial (2024 · The Lancet Respiratory Medicine · 被引 42)
• Effects of combined inoculation of arbuscular mycorrhizal fungi and plant growth-promoting rhizosphere bacteria on seedling growth and rhizosphere microecology (2025 · Frontiers in Microbiology · 被引 30)
• Consensus on the lung cancer management after third-generation EGFR-TKI resistance (2024 · The Lancet Regional Health - Western Pacific · 被引 27)
• A bibliometric analysis of immune-related adverse events in cancer patients and a meta-analysis of immune-related adverse events in patients with hepatocellular carcinoma. (2024 · PubMed · 被引 21)
• Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK-029A in Treatment-Naive Patients With Advanced NSCLC Harboring EGFR Exon 20 Insertion Mutations: A Phase 1 Trial (2023 · Journal of Thoracic Oncology · 被引 16)